<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30397617</article-id><article-id pub-id-type="pmc">6205790</article-id><article-id pub-id-type="publisher-id">132</article-id><article-id pub-id-type="doi">10.1186/s41038-018-0132-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Valuable prognostic indicators for severe burn sepsis with inhalation lesion: age, platelet count, and procalcitonin</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xu</surname><given-names>Yichao</given-names></name><address><email>549404562@qq.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Jin</surname><given-names>Xinyuan</given-names></name><address><email>xinyuan_jin@126.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5697-9225</contrib-id><name><surname>Shao</surname><given-names>Xiaonan</given-names></name><address><phone>+86-0-13776885831</phone><email>scorey@sina.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zheng</surname><given-names>Feng</given-names></name><address><phone>+86-0-13775061188</phone><email>zfccm@czfph.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Hong</given-names></name><address><email>hover_23@163.com</email></address><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1758 0478</institution-id><institution-id institution-id-type="GRID">grid.411176.4</institution-id><institution>Department of Burns, </institution><institution>Fujian Medical University Union Hospital, </institution></institution-wrap>Fuzhou, 350000 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution>Department of Burn Plastic Surgery, </institution><institution>The Affiliated Suzhou Hospital of Nanjing Medical University, </institution></institution-wrap>Suzhou, 215008 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.452253.7</institution-id><institution>Department of Nuclear Medicine, </institution><institution>The Third Affiliated Hospital of Soochow University, </institution></institution-wrap>Changzhou, 213003 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.452253.7</institution-id><institution>Department of Critical Care Medicine, </institution><institution>The Third Affiliated Hospital of Soochow University, </institution></institution-wrap>Changzhou, 213003 China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.452253.7</institution-id><institution>Department of Plastic Surgery and Burns, </institution><institution>The Third Affiliated Hospital of Soochow University, </institution></institution-wrap>Changzhou, 213003 China </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>6</volume><elocation-id>29</elocation-id><history><date date-type="received"><day>14</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>25</day><month>9</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Severe burn sepsis can lead to high mortality. We explored the valuable prognostic indicators for severe burn sepsis with inhalation lesion.</p></sec><sec><title>Methods</title><p id="Par2">Thirty-eight severe burn patients with sepsis who were admitted to the Third Affiliated Hospital of Soochow University from August 2014 to December 2017 were retrospectively analyzed. Among them, 22 patients were assigned to the death group and 16 patients to the survival group. Their general information, vital signs, and blood index including serum procalcitonin (PCT) and C-reactive protein (CRP) levels at admission, diagnosis of sepsis, and 1-week post-diagnosis of sepsis were compared.</p></sec><sec><title>Results</title><p id="Par3">Patients in the death group were older and had lower platelet count (PLT) at diagnosis of sepsis and 1-week post-diagnosis as well as higher PCT level at 1-week post-diagnosis than patients in the survival group (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). According to receiver operating characteristic (ROC) curves, the above four indicators could be used to predict the prognosis, and the area under the curve (AUC) of PLT at diagnosis and 1-week post-diagnosis was larger (0.888 and 0.911), and PLT at diagnosis had the highest sensitivity and specificity (0.842 and 0.937). In addition, these patients were divided into two groups by the optimal cutoff age of 38&#x000a0;years. According to multivariate logistic regression analysis and COX regression analysis, only age group and PLT at diagnosis were statistically significant (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). The risk of death in the older group was 28 times higher than that in the younger group, and the risk of death increased by 3% for each unit reduction in PLT at diagnosis. Moreover, age group was an independent factor affecting the patients&#x02019; survival (<italic>&#x003b2;</italic>&#x02009;=&#x02009;&#x02212;&#x02009;1.370, <italic>p</italic>&#x02009;=&#x02009;0.026). Considering the survival time after sepsis, the mortality risk was lower for patients in the older group than for patients in the younger group (hazard ratio&#x000a0;(HR)&#x02009;=&#x02009;0.254, 95% confidence interval&#x000a0;(CI) 0.076&#x02013;0.851).</p></sec><sec><title>Conclusion</title><p id="Par4">Age, PLT at diagnosis of sepsis, and 1-week post-diagnosis as well as PCT level at 1-week post-diagnosis are indicators for the evaluation of prognosis of severe burn sepsis with inhalation lesion. Among them, PLT at diagnosis has the greatest prognostic value. In addition, age can predict the patients&#x02019; mortality and survival time after sepsis.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Burns</kwd><kwd>Sepsis</kwd><kwd>Age</kwd><kwd>Platelet count</kwd><kwd>Procalcitonin</kwd></kwd-group><funding-group><award-group><funding-source><institution>guiding research subject of Changzhou Municipal Health Bureau</institution></funding-source><award-id>WZ201702</award-id><principal-award-recipient><name><surname>Zheng</surname><given-names>Feng</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Suzhou Key Medical Center</institution></funding-source><award-id>Szzxj201506</award-id><principal-award-recipient><name><surname>Jin</surname><given-names>Xinyuan</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par19">Unlike other wounds, severe burns can lead to more intense and lasting systemic inflammatory response syndrome (SIRS) and a higher incidence of whole body infection and sepsis due to skin barrier damage and organ dysfunction [<xref ref-type="bibr" rid="CR1">1</xref>]. Its further development can lead to septic shock and multiple organ dysfunction syndrome (MODS) [<xref ref-type="bibr" rid="CR2">2</xref>] among others. A recent study demonstrated that mortality in patients with sepsis after burns was 34.4% [<xref ref-type="bibr" rid="CR3">3</xref>]. Currently, burn sepsis has become the main obstacle for the treatment of severe burns [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par20">Blood cultures are still the &#x0201c;golden standards&#x0201d; for definitive sepsis identification, but they require 48&#x02013;72&#x000a0;h and are unable to rapidly diagnose sepsis in burn patients. In addition, because of the usage of high-dose antibiotics at an early stage in the clinic, the positive detection rate of blood culture is very low, which would delay the diagnosis. Moreover, blood culture is vulnerable to external bacterial contamination, leading to misdiagnosis [<xref ref-type="bibr" rid="CR5">5</xref>]. At present, the indexes for clinical diagnosis of sepsis of burn patients, such as fever, white blood cells (WBC), increased neutrophil percentage (<italic>N</italic>%), thrombocytopenia, tachycardia, and tachypnea, all have a role in the determination of patients&#x02019; condition [<xref ref-type="bibr" rid="CR6">6</xref>]. Although these indexes are easy to monitor, they are not sensitive enough to infection. C-reactive protein (CRP) is an acute phase protein and considered as an indicator of early diagnosis of inflammation [<xref ref-type="bibr" rid="CR7">7</xref>]. But besides the infection, CRP is also affected greatly by many other conditions such as trauma, surgery, burns, tissue necrosis, immune-mediated inflammatory disease, and advanced cancers. Patients with severe burns do have a systematic inflammatory response (SIR). Therefore, it is very important to develop new methods for differential diagnosis between a pure inflammatory reaction and a true sepsis, due to microbiological invasion of the bloodstream [<xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par21">Previous reviews have shown that procalcitonin (PCT) may be used as an auxiliary index in clinical diagnosis of sepsis and a modality to reduce exposure of antibiotics to critically ill patients [<xref ref-type="bibr" rid="CR9">9</xref>] and may be the most promising biomarker of burn patients with sepsis [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Reports on the evaluation of prognostic indexes of severe burn sepsis with inhalation lesion are rare. Thus, the present study was designed to compare the changes in indexes and analyze their values in the prognosis of severe burn patients with sepsis.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Inclusion criteria and exclusion criteria</title><p id="Par22">Patients were enrolled in the study if they met the following criteria: (1) had burn area &#x0003e;&#x02009;30% total body surface area (TBSA) [<xref ref-type="bibr" rid="CR12">12</xref>] and burn grade of II&#x02013;III, (2) &#x02265;&#x02009;18&#x000a0;years old, (3) moderate to severe inhalation injury was diagnosed by clinical exam and bronchoscopy at admission [<xref ref-type="bibr" rid="CR13">13</xref>], and (4) sepsis was diagnosed based on the American Burn Association criteria [<xref ref-type="bibr" rid="CR6">6</xref>]. Patients were excluded if they met the following exclusion criteria: (1) had negative blood culture during the length of stay and (2) died of acute pulmonary edema or non-septic shock.</p></sec><sec id="Sec4"><title>Clinical information</title><p id="Par23">The study was approved by the Ethics Committee of the Third Affiliated Hospital of Soochow University. All patients and their family members signed the informed consent form. Patients&#x02019; medical records were anonymous. All patients including 30 males and 8 females were admitted to the Third Affiliated Hospital of Soochow University within 12&#x000a0;h of accident from August 2014 to December 2017. They were at the age of 20&#x02013;65&#x000a0;years old and given comprehensive treatments including anti-shock, anti-infection, protection of internal organ function, debridement, and early deep wound surgery as well as tracheotomy for patients with respiratory tract burns. Early application of blood purification was used for clearance of inflammatory mediators and the recovery of the patient&#x02019;s immune status, especially for those with a greater burn area (&#x02265;&#x02009;80% TBSA) [<xref ref-type="bibr" rid="CR14">14</xref>]. Patients with sepsis all had abdominal distension, bowel sounds weakened or disappeared, and the wounds were moist, dull, and with necrotic spot, and so on.</p><p id="Par24">In addition, patients with sepsis were diagnosed at 6&#x02013;31&#x000a0;days after injury. Among the 38 patients, 22 (57.9%) died at 4&#x02013;51&#x000a0;days post-diagnosis of sepsis, and 16 survived. For the 16 surviving patients, their conditions were improved after treatment and did not meet the diagnostic criteria for sepsis for three continuous days.</p></sec><sec id="Sec5"><title>Observation indexes</title><p id="Par25">Vital signs, blood tests, serum sodium (Na<sup>+</sup>), glucose (Glu), CRP, and serum CO<sub>2</sub> partial pressure (PaCO<sub>2</sub>) were recorded and measured every day after admission. Serum PCT levels were serially collected immediately after admission and in 3-day periods until discharge or death by automatic fluorescence immunoassay analyzer (Roche cobas8000), and its value of 0&#x02013;0.5&#x000a0;ng/mL was considered as normal. CRP was measured on BECKMAN COULTER AU5800, and its value in the range of 0&#x02013;3&#x000a0;mg/L was considered as normal. If multiple blood samples were measured within 1-week post-diagnosis of sepsis, their average was used.</p></sec><sec id="Sec6"><title>Statistical analysis</title><p id="Par26">Data were analyzed using SPSS 13.0 software. Measurement data with normal distribution were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation (mean&#x02009;&#x000b1;SD). Measurement data with non-normal distribution were expressed as median (25&#x02013;75 centiles). Count data were expressed in number or percentage. Normally distributed data between the two different groups were compared using <italic>t</italic> test, and differences in rates were compared using the <italic>&#x003c7;</italic><sup>2</sup> test. Two sets of data with abnormal distribution were compared using the Mann-Whitney <italic>U</italic> rank sum test. Receiver operating characteristic (ROC) curves and area under the curve (AUC) were used to compare the prognosis efficacy of different indexes. The most accurate cutoff value was calculated by the Youden Index. Logistic regression analysis was applied to perform the univariate and multivariate analysis and calculate the regression coefficient and the odds ratio (OR). COX regression analysis was used to compare the influence of different indexes on survival time and calculate the hazard ratio (HR) and 95% confidence interval (CI). A value of&#x000a0;<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec7"><title>Results</title><sec id="Sec8"><title>General comparison of the patients</title><p id="Par27">There was no significant difference between the two groups in sex ratio, total burn area, area of III degree, and the time of diagnosis of sepsis (all <italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05). Patients in the death group were significantly older than patients in the survival group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), as shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>General comparison of patients in the&#x000a0;death and survival&#x000a0;groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Group</th><th rowspan="2">N</th><th colspan="2">Gender</th><th rowspan="2">Age (years)</th><th colspan="2">Burn area (%TBSA)</th><th rowspan="2">Time of diagnosis of sepsis (days)</th></tr><tr><th>Male</th><th>Female</th><th>Total area</th><th>Area with grade III burn</th></tr></thead><tbody><tr><td>Death</td><td char="." align="char">22</td><td char="." align="char">18</td><td>4</td><td>43&#x02009;&#x000b1;&#x02009;12</td><td>92&#x02009;&#x000b1;&#x02009;7</td><td>71&#x02009;&#x000b1;&#x02009;22</td><td>12&#x02009;&#x000b1;&#x02009;6</td></tr><tr><td>Survival</td><td char="." align="char">16</td><td char="." align="char">12</td><td>4</td><td>34&#x02009;&#x000b1;&#x02009;10</td><td>89&#x02009;&#x000b1;&#x02009;11</td><td>69&#x02009;&#x000b1;&#x02009;20</td><td>15&#x02009;&#x000b1;&#x02009;8</td></tr><tr><td colspan="2">
<italic>P</italic>
</td><td colspan="2">0.698</td><td>0.039</td><td>0.410</td><td>0.770</td><td>0.130</td></tr></tbody></table><table-wrap-foot><p>Measurement data with normal distribution were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation</p><p><italic>TBSA</italic> total body surface area</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Comparison of all indexes at admission, diagnosis of sepsis, and 1-week post-diagnosis</title><p id="Par28">Comparison of all indexes at admission showed that there were no significant differences between patients in the death group and in the survival group (all <italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05), as shown in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Comparison of all indexes at diagnosis of sepsis showed that platelet count (PLT) in the death group was significantly lower than that in the survival group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), as shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. Comparison of serum WBC, <italic>N</italic>%, PLT, PCT, and CRP at 1-week post-diagnosis showed that PLT and PCT were significantly different (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) between patients in the death group and in the survival group, as shown in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Comparison of indexes at admission between the&#x000a0;death and survival&#x000a0;groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Max. body temp (&#x000b0;C)</th><th>Min. body temp (&#x000b0;C)</th><th>Heart rate (beats/min)</th><th>WBC (&#x000d7;&#x02009;10<sup>9</sup>/L)</th><th><italic>N</italic>% </th><th>PLT (&#x000d7;&#x02009;10<sup>9</sup>/L)</th><th>Na<sup>+</sup>(mmol/L)</th><th>Glu (mmol/L)</th><th>PCT (ng/mL)</th><th>CRP (mg/L)</th><th>PaCO<sub>2</sub>(mmHg)</th></tr></thead><tbody><tr><td>Death</td><td>37.1&#x02009;&#x000b1;&#x02009;0.9</td><td>36.4&#x02009;&#x000b1;&#x02009;1.1</td><td>131&#x02009;&#x000b1;&#x02009;16</td><td>31.49&#x02009;&#x000b1;&#x02009;15.25</td><td>86.5&#x02009;&#x000b1;&#x02009;6.0</td><td>200&#x02009;&#x000b1;&#x02009;122</td><td>140.8&#x02009;&#x000b1;&#x02009;6.9</td><td>8.99&#x02009;&#x000b1;&#x02009;3.47</td><td>10.6 (4.9, 21.4)</td><td>23.9 (9.3, 27.7)</td><td>39.7&#x02009;&#x000b1;&#x02009;8.0</td></tr><tr><td>Survival</td><td>37.2&#x02009;&#x000b1;&#x02009;0.9</td><td>36.3&#x02009;&#x000b1;&#x02009;0.5</td><td>126&#x02009;&#x000b1;&#x02009;24</td><td>24.79&#x02009;&#x000b1;&#x02009;13.56</td><td>85.6&#x02009;&#x000b1;&#x02009;5.4</td><td>172&#x02009;&#x000b1;&#x02009;139</td><td>139.0&#x02009;&#x000b1;&#x02009;5.6</td><td>8.28&#x02009;&#x000b1;&#x02009;3.85</td><td>4.6 (0.5, 9.2)</td><td>8.5 (2.2, 25.1)</td><td>35.2&#x02009;&#x000b1;&#x02009;5.3</td></tr><tr><td/><td/><td/><td/><td/><td/><td/><td>0.935</td><td>0.492</td><td>1.470</td><td>1.610</td><td>1.667</td></tr><tr><td>
<italic>P</italic>
</td><td>0.869</td><td>0.723</td><td>0.490</td><td>0.193</td><td>0.657</td><td>0.545</td><td>0.357</td><td>0.627</td><td>0.156</td><td>0.108</td><td>0.107</td></tr></tbody></table><table-wrap-foot><p>Measurement data with normal distribution were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation. Measurement data with non-normal distribution were expressed as median (25&#x02013;75 centiles)</p><p><italic>WBC</italic> white blood cells, <italic>N%</italic> neutrophil percentage, <italic>PLT</italic> platelet count, <italic>Na</italic><sup><italic>+</italic></sup> serum sodium, <italic>Glu</italic> glucose, <italic>PCT</italic> procalcitonin, <italic>CRP</italic> C-reactive protein, <italic>PaCO</italic><sub><italic>2</italic></sub> serum CO<sub>2</sub> partial pressure</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Comparison of indexes at diagnosis of sepsis between the death and survival groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>Max. body temp (&#x000b0;C)</th><th>Min. body temp (&#x000b0;C)</th><th>Heart rate (beats/min)</th><th>WBC (&#x000d7;&#x02009;10<sup>9</sup>/L)</th><th><italic>N</italic>% </th><th>PLT (&#x000d7;&#x02009;10<sup>9</sup>/L)</th><th>Na<sup>+</sup>(mmol/L)</th><th>Glu (mmol/L)</th><th>PCT (ng/mL)</th><th>CRP (mg/L)</th><th>PaCO<sub>2</sub>(mmHg)</th></tr></thead><tbody><tr><td>Death</td><td>38.7&#x02009;&#x000b1;&#x02009;1.6</td><td>36.7&#x02009;&#x000b1;&#x02009;1.3</td><td>125&#x02009;&#x000b1;&#x02009;23</td><td>13.35&#x02009;&#x000b1;&#x02009;6.81</td><td>87.9&#x02009;&#x000b1;&#x02009;7.4</td><td>94&#x02009;&#x000b1;&#x02009;63</td><td>146.0&#x02009;&#x000b1;&#x02009;9.9</td><td>10.00&#x02009;&#x000b1;&#x02009;6.64</td><td>3.1 (1.2, 8.6)</td><td>24.8 (24.3, 26.3)</td><td>38.2&#x02009;&#x000b1;&#x02009;8.0</td></tr><tr><td>Survival</td><td>39.3&#x02009;&#x000b1;&#x02009;0.7</td><td>36.8&#x02009;&#x000b1;&#x02009;0.9</td><td>137&#x02009;&#x000b1;&#x02009;11</td><td>15.34&#x02009;&#x000b1;&#x02009;6.42</td><td>87.6&#x02009;&#x000b1;&#x02009;4.3</td><td>256&#x02009;&#x000b1;&#x02009;126</td><td>143.1&#x02009;&#x000b1;&#x02009;12.2</td><td>9.84&#x02009;&#x000b1;&#x02009;6.22</td><td>1.3 (0.8, 4.3)</td><td>23.4 (17.6, 24.7)</td><td>36.4&#x02009;&#x000b1;&#x02009;6.5</td></tr><tr><td>
<italic>P</italic>
</td><td>0.236</td><td>0.768</td><td>0.080</td><td>0.382</td><td>0.892</td><td>0.000</td><td>0.427</td><td>0.948</td><td>0.172</td><td>0.079</td><td>0.528</td></tr></tbody></table><table-wrap-foot><p>Measurement data with normal distribution were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation. Measurement data with non-normal distribution were expressed as median (25&#x02013;75 centiles)</p><p><italic>WBC</italic> white blood cells, <italic>N%</italic> neutrophil percentage, <italic>PLT</italic> platelet count, <italic>Na</italic><sup><italic>+</italic></sup> serum sodium, <italic>Glu</italic> glucose, <italic>PCT</italic> procalcitonin, <italic>CRP</italic> C-reactive protein, <italic>PaCO</italic><sub><italic>2</italic></sub> serum CO<sub>2</sub> partial pressure</p></table-wrap-foot></table-wrap><table-wrap id="Tab4"><label>Table 4</label><caption><p>Comparison of indexes at 1-week post-diagnosis of sepsis between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Group</th><th>WBC (&#x000d7;&#x02009;10<sup>9</sup>/L)</th><th><italic>N</italic>%</th><th>PLT (&#x000d7;&#x02009;10<sup>9</sup>/L)</th><th>PCT (ng/mL)</th><th>CRP (mg/L)</th></tr></thead><tbody><tr><td>Death</td><td>11.26&#x02009;&#x000b1;&#x02009;4.96</td><td>86.5&#x02009;&#x000b1;&#x02009;5.4</td><td>97&#x02009;&#x000b1;&#x02009;72</td><td>4.3 (2.3, 8.7)</td><td>24.2 (23.9, 24.6)</td></tr><tr><td>Survival</td><td>11.03&#x02009;&#x000b1;&#x02009;2.30</td><td>83.0&#x02009;&#x000b1;&#x02009;5.4</td><td>268&#x02009;&#x000b1;&#x02009;113</td><td>2.2 (1.0, 4.1)</td><td>24.4 (24.0, 28.4)</td></tr><tr><td/><td>0.125</td><td>1.494</td><td>&#x02212;&#x02009;4.351</td><td>2.500</td><td>1.016</td></tr><tr><td>
<italic>P</italic>
</td><td>0.902</td><td>0.151</td><td>0.000</td><td>0.011</td><td>0.371</td></tr></tbody></table><table-wrap-foot><p>Measurement data with normal distribution were expressed as mean&#x02009;&#x000b1;&#x02009;SD. Measurement data with non-normal distribution were expressed as median (25&#x02013;75 centiles)</p><p><italic>WBC</italic> white blood cells, <italic>N%</italic> neutrophil percentage, <italic>PLT</italic> platelet count, <italic>PCT</italic> procalcitonin, <italic>CRP</italic> C-reactive protein</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Analyses of indexes using ROC curves</title><p id="Par29">ROC curves showed that age, PLT at diagnosis, and 1-week post-diagnosis, and PCT at 1-week post-diagnosis could be used to predict the prognosis of severe burn sepsis (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), as shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref>. The AUC of PLT at diagnosis and 1-week post-diagnosis were larger (0.888 and 0.911), and PLT at diagnosis had the highest sensitivity and specificity (0.842 and 0.937), followed by PCT at 1-week post-diagnosis and age. The best cutoff value for age was 38&#x000a0;years old; therefore, patients were divided into &#x02265;&#x02009;38&#x000a0;years old group (20 cases) and &#x0003c;&#x02009;38&#x000a0;years old group (18 cases).<fig id="Fig1"><label>Fig. 1</label><caption><p>Receiver operating characteristic (ROC) curves of prognosis of severe burn sepsis by age, platelet count (PLT) at diagnosis of sepsis, PLT and procalcitonin (PCT) at 1-week post-diagnosis. The area under the curve (AUC) of PLT at diagnosis and 1-week post-diagnosis was larger (0.888 and 0.911)</p></caption><graphic xlink:href="41038_2018_132_Fig1_HTML" id="MO1"/></fig><table-wrap id="Tab5"><label>Table 5</label><caption><p>Prognostic value of various indexes in severe burn patients with sepsis by receiver operating characteristic (ROC) curves</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Indexes</th><th>AUC</th><th>
<italic>P</italic>
</th><th>95% CI</th><th>Cutoff</th><th>Sensitivity</th><th>Specificity</th></tr></thead><tbody><tr><td>Age (years)</td><td>0.673</td><td>0.044</td><td>0.522&#x02013;0.865</td><td>38</td><td>0.682</td><td>0.687</td></tr><tr><td>PLT at diagnosis of sepsis (&#x000d7;&#x02009;10<sup>9</sup>/L)</td><td>0.888</td><td>0.000</td><td>0.762&#x02013;1.014</td><td>150</td><td>0.842</td><td>0.937</td></tr><tr><td>PLT at 1-week post-diagnosis of sepsis (&#x000d7;&#x02009;10<sup>9</sup>/L)</td><td>0.911</td><td>0.002</td><td>1.790&#x02013;1.031</td><td>161</td><td>0.786</td><td>0.875</td></tr><tr><td>PCT at admission (ng/mL)</td><td>0.700</td><td>0.142</td><td>0.455&#x02013;0.945</td><td>10.3</td><td>0.444</td><td>0.900</td></tr><tr><td>PCT at diagnosis of sepsis (ng/mL)</td><td>0.652</td><td>0.104</td><td>0.448&#x02013;0.857</td><td>2.0</td><td>0.667</td><td>0.643</td></tr><tr><td>PCT at 1-week post-diagnosis of sepsis (ng/mL)</td><td>0.745</td><td>0.012</td><td>0.586&#x02013;0.905</td><td>2.4</td><td>0.750</td><td>0.697</td></tr></tbody></table><table-wrap-foot><p><italic>AUC</italic> area under the curve, <italic>CI</italic> confidence interval, <italic>PLT</italic> platelet count, <italic>PCT</italic> procalcitonin</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec11"><title>Logistic regression analysis and COX regression analysis</title><p id="Par30">Univariate logistic analysis showed that the heart rate and CRP at diagnosis were not statistically significant between the two groups (all <italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05). In addition, considering that PLT at 1-week post-diagnosis had a good correlation with PLT at diagnosis (<italic>r</italic>&#x02009;=&#x02009;0.872, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) and PCT at 1-week post-diagnosis (<italic>r</italic>&#x02009;=&#x02009;&#x02212;&#x02009;0.563, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) as well as clinical significance of PLT at diagnosis, age group, PLT at diagnosis, and PCT at 1-week post-diagnosis were included in the multivariate logistic regression analysis and COX regression analysis. Among the three variables included in the logistic model, only the age group and PLT at diagnosis were statistically significant (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), as shown in Table&#x000a0;<xref rid="Tab6" ref-type="table">6</xref>. The risk of death in the older group was 28 times higher than that in the younger group, and the risk of death increased by 3% for each unit reduction in PLT at diagnosis. COX regression analysis showed that the age group was an independent factor affecting survival (<italic>&#x003b2;</italic>&#x02009;=&#x02009;&#x02212;&#x02009;1.370, <italic>p</italic>&#x02009;=&#x02009;0.026). Considering the survival time after sepsis, the mortality risk in the older group was lower than that in the younger group (HR&#x02009;=&#x02009;0.254, 95% CI 0.076&#x02013;0.851), as shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>.<table-wrap id="Tab6"><label>Table 6</label><caption><p>Logistic regression analysis of the impact of various factors on prognosis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Factors</th><th>
<italic>&#x003b2;</italic>
</th><th>
<italic>P</italic>
</th><th>OR</th><th>95% CI</th></tr></thead><tbody><tr><td>Age group (&#x02265;&#x02009;38&#x000a0;years)</td><td>3.347</td><td>0.020</td><td>28.425</td><td>1.688&#x02013;478.716</td></tr><tr><td>PLT at diagnosis of sepsis (&#x000d7;&#x02009;10<sup>9</sup>/L)</td><td>&#x02212;&#x02009;0.027</td><td>0.007</td><td>0.973</td><td>0.954&#x02013;0.992</td></tr></tbody></table><table-wrap-foot><p><italic>OR</italic> odds ratio, <italic>CI</italic> confidence interval, <italic>PLT</italic> platelet count</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Age-based survival curves with a cutoff of 38&#x000a0;years old. COX regression analysis showed that age group was an independent factor affecting survival (<italic>&#x003b2;</italic>&#x02009;=&#x02009;&#x02212;&#x02009;1.370, <italic>p</italic>&#x02009;=&#x02009;0.026). Considering survival time after sepsis, the mortality risk in the older group was lower than that in the younger group (hazard ratio&#x02009;=&#x02009;0.254, 95% confidence interval 0.076&#x02013;0.851)</p></caption><graphic xlink:href="41038_2018_132_Fig2_HTML" id="MO2"/></fig></p></sec></sec><sec id="Sec12"><title>Discussion</title><sec id="Sec13"><title>Mortality of severe burn patients with sepsis</title><p id="Par31">A previous study has shown that the degree of inhalation injury is related to the burn-related mortality [<xref ref-type="bibr" rid="CR15">15</xref>]. In addition, regardless of the degree of burns, burn patients with severe inhalation injury are directly diagnosed as severe burns [<xref ref-type="bibr" rid="CR16">16</xref>]. Several retrospective clinical studies have shown that the mortality of severe burn patients with sepsis can be as high as 58.9% [<xref ref-type="bibr" rid="CR17">17</xref>]. In our study, the mortality of patients with sepsis was 57.9%, similar to that in the literature. High mortality suggests that early diagnosis and aggressive treatment including early tracheotomy should be adopted to improve the survival of patients.</p></sec><sec id="Sec14"><title>Age, sepsis mortality, and survival time</title><p id="Par32">A previous report has shown that age has a positive linear correlation with the mortality of burn patients [<xref ref-type="bibr" rid="CR18">18</xref>]. Our study also showed that patients in the death group were significantly older. ROC curves indicated that the best cutoff age was 38&#x000a0;years old. Because most of the enrolled patients were young, the optimal cutoff age was low. In addition, age was an independent factor affecting the survival time after sepsis. These results were interesting and indicated that although older patients had higher mortality after severe burn sepsis, they had longer survival time after sepsis than younger patients. Burn patients often have chronic baseline inflammation responses [<xref ref-type="bibr" rid="CR19">19</xref>] and immune disorders [<xref ref-type="bibr" rid="CR1">1</xref>]. However, SIR is weaker in older patients than in younger patients [<xref ref-type="bibr" rid="CR20">20</xref>], so older patients may be more resistant to septic shock or MODS.</p></sec><sec id="Sec15"><title>Clinical symptoms and common indexes for prognosis</title><p id="Par33">Although the clinical symptoms and common indexes of burn patients such as body temperature, and heart rate can be easily measured and have some relevance to infection, they cannot be used as sensitive indexes of infection [<xref ref-type="bibr" rid="CR8">8</xref>]. Increase in WBC or <italic>N</italic>% is one of the diagnostic criteria for burn patients with sepsis [<xref ref-type="bibr" rid="CR6">6</xref>]. But WBC is affected by many other factors such as levels of catecholamine and glucocorticoid, acute hemorrhage, myocardial infarction, and the like. Thus, WBC is of little significance for diagnosis of infection or sepsis. An increase in WBC in burn patients is not a direct evidence for the diagnosis of infection [<xref ref-type="bibr" rid="CR13">13</xref>]. Although Na<sup>+</sup> and Glu have been used for diagnosis of burn patients with sepsis [<xref ref-type="bibr" rid="CR6">6</xref>], our results indicated that they had limited prognostic values.</p><p id="Par34">It has been reported that CRP level was increased in 12&#x02013;24&#x000a0;h of pathogenesis, maintained at high level in 20&#x02013;72&#x000a0;h, and returned to baseline in 3&#x02013;7&#x000a0;days [<xref ref-type="bibr" rid="CR21">21</xref>]. In addition, growing evidences have indicated that CRP is not only an inflammatory marker but also directly involved in the inflammatory process itself. Dehne et al. investigated CRP level in 24 cases of severe burn patients and the effects of TBSA on CRP level [<xref ref-type="bibr" rid="CR12">12</xref>]. They found that CRP level continuously rose in patients with TBSA &#x0003e;&#x02009;30%. Wu et al. confirmed that CRP levels were not significantly higher among burn patients with septic shock or bloodstream infection [<xref ref-type="bibr" rid="CR13">13</xref>]. Our results showed that CRP level was not significantly different between the two groups, indicating it had limited prognostic value.</p></sec><sec id="Sec16"><title>PLT and prognosis</title><p id="Par35">Thrombocytopenia (&#x0003c;&#x02009;100&#x02009;&#x000d7;&#x02009;10<sup>9</sup>/L) is just one of the sums of clinical criteria used for sepsis diagnosis [<xref ref-type="bibr" rid="CR6">6</xref>] and has no value when used alone. Thrombocytopenia occurs in 35&#x02013;59% of patients with sepsis and in 79.6% of patients with positive blood culture. In addition, thrombocytopenia is a dangerous sign of risk of death in patients with sepsis [<xref ref-type="bibr" rid="CR22">22</xref>]. The recovery of minimal PLT is associated with the reduced mortality [<xref ref-type="bibr" rid="CR23">23</xref>]. Marck et al. found that PLT reached its minimum 3&#x000a0;days after burn and recovered to its peak 15&#x000a0;days after injury [<xref ref-type="bibr" rid="CR24">24</xref>]. Patients might have temporary thrombocytosis. During this process, affected by the burn area, age, and sepsis, the area of severe burns, elder age, and low PLT peak count can be used to predict mortality. In this study, the best cutoff PLT at diagnosis of sepsis for mortality prediction of burn patients with sepsis was 150&#x02009;&#x000d7;&#x02009;10<sup>9</sup>/L. The reason for such a high cutoff was that sepsis was diagnosed around the peak PLT proposed by Marck et al. [<xref ref-type="bibr" rid="CR24">24</xref>]. In addition, multivariate analysis suggested that PLT at diagnosis was an independent protective factor affecting prognosis, consistent with the results of ROC.</p></sec><sec id="Sec17"><title>Serum PCT level and prognosis</title><p id="Par36">Serum PCT level is closely related to the severity of infection. Higher serum PCT level prompts more severe condition of patients. The continuous increase in serum PCT suggests high mortality of patients [<xref ref-type="bibr" rid="CR25">25</xref>]. The decrease in post-treatment serum PCT level reflects the effectiveness of anti-infection treatment. Effective treatment and infection control could lead to the rapid restoration of PCT to the normal level [<xref ref-type="bibr" rid="CR26">26</xref>]. This may be due to that the severity of sepsis depends on SIR caused by a serious bacterial infection. The greater the response, the higher the mortality [<xref ref-type="bibr" rid="CR27">27</xref>]. Therefore, serum PCT level not only has the effect on the development of burn sepsis but also can predict the prognosis [<xref ref-type="bibr" rid="CR28">28</xref>], thus is of important guiding significance for implementation of clinical intervention as soon as possible [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p id="Par37">Kim et al. reported that serum PCT level within the first 48&#x000a0;h after burn, especially within the first 14&#x02013;24&#x000a0;h after burn, was a useful prognostic indicator for mortality of patients with sepsis [<xref ref-type="bibr" rid="CR30">30</xref>]. In this study, serum PCT level at 1-week post-sepsis was significantly different between the two groups. Its optimal cutoff value for mortality prediction was 2.4&#x000a0;ng/mL. Wang et al. reported that the cutoff of PCT at diagnosis of sepsis for mortality prediction was 10.9&#x000a0;ng/mL [<xref ref-type="bibr" rid="CR29">29</xref>]. This discrepancy is possibly due to the following reasons. Firstly, burn patients in different studies may have different clinical manifestations such as burn area, burn type, inhalation injury, and other complications. Secondly, these studies may differ in sample size, which may affect the reliability of the results [<xref ref-type="bibr" rid="CR10">10</xref>]. Thirdly, PCT measurements from different instruments show variability. Finally, blood samples may be collected at different times. Because after bacterial toxins entering the bloodstream, serum PCT level increases within 3&#x02013;6&#x000a0;h and reaches its peak within 6&#x02013;22&#x000a0;h. In addition, PCT has a long half-life (25&#x02013;30&#x000a0;h); thus, its serum concentration can maintain increasing within 12&#x02013;48&#x000a0;h [<xref ref-type="bibr" rid="CR31">31</xref>]. Therefore, PCT level is different in septic shock peak period from that in the recovery period. Therefore, tracking the trend of PCT level after sepsis is of importance to understand the prognosis of patients with severe burn sepsis.</p></sec></sec><sec id="Sec18"><title>Conclusions</title><p id="Par38">In conclusion, age, PLT at diagnosis of sepsis, and 1-week post-diagnosis as well as PCT level at 1-week post-diagnosis are indicators for the prognosis of severe burn sepsis with inhalation lesion. Among them, PLT at diagnosis has the greatest prognostic value. In addition, age can predict patients&#x02019; mortality and survival time after sepsis. Application of these indexes to timely assess the patients&#x02019; prognosis may be of guiding significance for clinical intervention. However, the study was only a single-center retrospective study and had some limitations. Thus, the conclusion of the study needs to be further studied with a larger sample size and at different treatment centers.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AUC</term><def><p id="Par5">Area under the curve</p></def></def-item><def-item><term>CI</term><def><p id="Par6">Confidence interval</p></def></def-item><def-item><term>CRP</term><def><p id="Par7">C-reactive protein</p></def></def-item><def-item><term>Glu</term><def><p id="Par8">Glucose</p></def></def-item><def-item><term>HR</term><def><p id="Par9">Hazard ratio</p></def></def-item><def-item><term>MODS</term><def><p id="Par10">Multiple organ dysfunction syndrome</p></def></def-item><def-item><term>Na<sup>+</sup></term><def><p id="Par11">Serum sodium</p></def></def-item><def-item><term>OR</term><def><p id="Par12">Odds ratio</p></def></def-item><def-item><term>PaCO<sub>2</sub></term><def><p id="Par13">Serum CO<sub>2</sub> partial pressure</p></def></def-item><def-item><term>PCT</term><def><p id="Par14">Procalcitonin</p></def></def-item><def-item><term>PLT</term><def><p id="Par15">Platelet count</p></def></def-item><def-item><term>SIR</term><def><p id="Par16">Systematic inflammatory response</p></def></def-item><def-item><term>SIRS</term><def><p id="Par17">Systemic inflammatory response syndrome</p></def></def-item><def-item><term>WBC</term><def><p id="Par18">White blood cells</p></def></def-item></def-list></glossary><ack><sec id="FPar1"><title>Funding</title><p id="Par39">This work was supported by guiding research subject of Changzhou Municipal Health Bureau (WZ201702) and Suzhou Key Medical Center (Szzxj201506).</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par40">All data generated or analyzed during this study are included in this published article.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>YX, XJ, and HZ conceived the study and drafted the manuscript. YX and XJ carried out the lab testing. XS and FZ participated in the design of the study and performed the statistical analysis. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>This study was approved by the Ethics Committee of the Soochow University. All patients and their family members signed the informed consent form.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declare that they have no competing interest.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girardot</surname><given-names>T</given-names></name><name><surname>Rimmele</surname><given-names>T</given-names></name><name><surname>Venet</surname><given-names>F</given-names></name><name><surname>Monneret</surname><given-names>G</given-names></name></person-group><article-title>Apoptosis-induced lymphopenia in sepsis and other severe injuries</article-title><source>Apoptosis</source><year>2017</year><volume>22</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1007/s10495-016-1325-3</pub-id><pub-id pub-id-type="pmid">27812767</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>MA</given-names></name><name><surname>Coulson</surname><given-names>AK</given-names></name><name><surname>Hull</surname><given-names>JH</given-names></name><name><surname>Ho</surname><given-names>TB</given-names></name></person-group><article-title>Bloodstream infection: early treatment strategies in sepsis</article-title><source>Bmj</source><year>2008</year><volume>336</volume><fpage>521</fpage><pub-id pub-id-type="doi">10.1136/bmj.39507.433333.80</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belba</surname><given-names>MK</given-names></name><name><surname>Petrela</surname><given-names>EY</given-names></name><name><surname>Belba</surname><given-names>AG</given-names></name></person-group><article-title>Epidemiology and outcome analysis of sepsis and organ dysfunction/failure after burns</article-title><source>Burns</source><year>2017</year><volume>43</volume><fpage>1335</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2017.02.017</pub-id><pub-id pub-id-type="pmid">28545914</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunez Lopez</surname><given-names>O</given-names></name><name><surname>Cambiaso-Daniel</surname><given-names>J</given-names></name><name><surname>Branski</surname><given-names>LK</given-names></name><name><surname>Norbury</surname><given-names>WB</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><article-title>Predicting and managing sepsis in burn patients: current perspectives</article-title><source>Ther Clin Risk Manag</source><year>2017</year><volume>13</volume><fpage>1107</fpage><lpage>1117</lpage><pub-id pub-id-type="doi">10.2147/TCRM.S119938</pub-id><pub-id pub-id-type="pmid">28894374</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiesa</surname><given-names>C</given-names></name><name><surname>Panero</surname><given-names>A</given-names></name><name><surname>Osborn</surname><given-names>JF</given-names></name><name><surname>Simonetti</surname><given-names>AF</given-names></name><name><surname>Pacifico</surname><given-names>L</given-names></name></person-group><article-title>Diagnosis of neonatal sepsis: a clinical and laboratory challenge</article-title><source>Clin Chem</source><year>2004</year><volume>50</volume><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2003.025171</pub-id><pub-id pub-id-type="pmid">14752012</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>DG</given-names></name><name><surname>Saffle</surname><given-names>JR</given-names></name><name><surname>JHt</surname><given-names>H</given-names></name><name><surname>Gamelli</surname><given-names>RL</given-names></name><name><surname>Palmieri</surname><given-names>TL</given-names></name><name><surname>Horton</surname><given-names>JW</given-names></name><etal/></person-group><article-title>American Burn Association consensus conference to define sepsis and infection in burns</article-title><source>J Burn Care Res</source><year>2007</year><volume>28</volume><fpage>776</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e3181599bc9</pub-id><pub-id pub-id-type="pmid">17925660</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faix</surname><given-names>JD</given-names></name></person-group><article-title>Biomarkers of sepsis</article-title><source>Crit Rev Clin Lab Sci</source><year>2013</year><volume>50</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.3109/10408363.2013.764490</pub-id><pub-id pub-id-type="pmid">23480440</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barati</surname><given-names>M</given-names></name><name><surname>Alinejad</surname><given-names>F</given-names></name><name><surname>Bahar</surname><given-names>MA</given-names></name><name><surname>Tabrisi</surname><given-names>MS</given-names></name><name><surname>Shamshiri</surname><given-names>AR</given-names></name><name><surname>Bodouhi</surname><given-names>NO</given-names></name><etal/></person-group><article-title>Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases</article-title><source>Burns</source><year>2008</year><volume>34</volume><fpage>770</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2008.01.014</pub-id><pub-id pub-id-type="pmid">18513877</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>EA</given-names></name><name><surname>Wood</surname><given-names>GL</given-names></name><name><surname>Wade</surname><given-names>CE</given-names></name></person-group><article-title>Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature</article-title><source>Burns</source><year>2011</year><volume>37</volume><fpage>549</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2010.04.013</pub-id><pub-id pub-id-type="pmid">20537467</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name></person-group><article-title>Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis</article-title><source>Burns</source><year>2015</year><volume>41</volume><fpage>502</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2014.08.019</pub-id><pub-id pub-id-type="pmid">25648378</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabral</surname><given-names>L</given-names></name><name><surname>Afreixo</surname><given-names>V</given-names></name><name><surname>Santos</surname><given-names>F</given-names></name><name><surname>Almeida</surname><given-names>L</given-names></name><name><surname>Paiva</surname><given-names>JA</given-names></name></person-group><article-title>Procalcitonin for the early diagnosis of sepsis in burn patients: a retrospective study</article-title><source>Burns</source><year>2017</year><volume>43</volume><fpage>1427</fpage><lpage>1434</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2017.03.026</pub-id><pub-id pub-id-type="pmid">28454850</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehne</surname><given-names>MG</given-names></name><name><surname>Sablotzki</surname><given-names>A</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Muhling</surname><given-names>J</given-names></name><name><surname>Dietrich</surname><given-names>FE</given-names></name><name><surname>Hempelmann</surname><given-names>G</given-names></name></person-group><article-title>Alterations of acute phase reaction and cytokine production in patients following severe burn injury</article-title><source>Burns</source><year>2002</year><volume>28</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1016/S0305-4179(02)00050-5</pub-id><pub-id pub-id-type="pmid">12220910</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>RX</given-names></name><name><surname>Chiu</surname><given-names>CC</given-names></name><name><surname>Lin</surname><given-names>TC</given-names></name><name><surname>Yang</surname><given-names>YS</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Procalcitonin as a diagnostic biomarker for septic shock and bloodstream infection in burn patients from the Formosa Fun Coast dust explosion</article-title><source>J Microbiol Immunol Infect</source><year>2017</year><volume>50</volume><fpage>872</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2016.08.021</pub-id><pub-id pub-id-type="pmid">28690030</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>You</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Luo</surname><given-names>GX</given-names></name><name><surname>Dang</surname><given-names>YM</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>GT</given-names></name><etal/></person-group><article-title>Early application of continuous high-volume haemofiltration can reduce sepsis and improve the prognosis of patients with severe burns</article-title><source>Crit Care</source><year>2018</year><volume>22</volume><fpage>173</fpage><pub-id pub-id-type="doi">10.1186/s13054-018-2095-9</pub-id><pub-id pub-id-type="pmid">29980222</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inhalation injury in Southwest China--the evolution of care</article-title><source>Burns</source><year>2010</year><volume>36</volume><fpage>506</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2009.07.008</pub-id><pub-id pub-id-type="pmid">19857928</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>XD</given-names></name><name><surname>Lin</surname><given-names>GA</given-names></name><name><surname>Zhao</surname><given-names>GH</given-names></name><name><surname>Li</surname><given-names>WJ</given-names></name><name><surname>Jiao</surname><given-names>QY</given-names></name><name><surname>Yuan</surname><given-names>SA</given-names></name></person-group><article-title>Categorization of burn severity</article-title><source>Zhonghua Shao Shang Za Zhi</source><year>2007</year><volume>23</volume><fpage>362</fpage><lpage>364</lpage><pub-id pub-id-type="pmid">18396765</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>YM</given-names></name><name><surname>Sheng</surname><given-names>ZY</given-names></name><name><surname>Chai</surname><given-names>JK</given-names></name></person-group><article-title>The pathogenesis and management of severe sepsis after burns</article-title><source>Zhonghua Shao Shang Za Zhi</source><year>2008</year><volume>24</volume><fpage>337</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">19103010</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinvall</surname><given-names>I</given-names></name><name><surname>Elmasry</surname><given-names>M</given-names></name><name><surname>Fredrikson</surname><given-names>M</given-names></name><name><surname>Sjoberg</surname><given-names>F</given-names></name></person-group><article-title>Standardised mortality ratio based on the sum of age and percentage total body surface area burned is an adequate quality indicator in burn care: an exploratory review</article-title><source>Burns</source><year>2016</year><volume>42</volume><fpage>28</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2015.10.032</pub-id><pub-id pub-id-type="pmid">26700877</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name><name><surname>Przkora</surname><given-names>R</given-names></name><name><surname>Pereira</surname><given-names>CT</given-names></name><name><surname>Oliveira</surname><given-names>HM</given-names></name><name><surname>Queiroz</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Cytokine expression profile over time in severely burned pediatric patients</article-title><source>Shock</source><year>2006</year><volume>26</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1097/01.shk.0000223120.26394.7d</pub-id><pub-id pub-id-type="pmid">16783192</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Vught</surname><given-names>LA</given-names></name><name><surname>Endeman</surname><given-names>H</given-names></name><name><surname>Meijvis</surname><given-names>SC</given-names></name><name><surname>Zwinderman</surname><given-names>AH</given-names></name><name><surname>Scicluna</surname><given-names>BP</given-names></name><name><surname>Biesma</surname><given-names>DH</given-names></name><etal/></person-group><article-title>The effect of age on the systemic inflammatory response in patients with community-acquired pneumonia</article-title><source>Clin Microbiol Infect</source><year>2014</year><volume>20</volume><fpage>1183</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12717</pub-id><pub-id pub-id-type="pmid">24930498</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabay</surname><given-names>C</given-names></name><name><surname>Kushner</surname><given-names>I</given-names></name></person-group><article-title>Acute-phase proteins and other systemic responses to inflammation</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><fpage>448</fpage><lpage>454</lpage><pub-id pub-id-type="doi">10.1056/NEJM199902113400607</pub-id><pub-id pub-id-type="pmid">9971870</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderschueren</surname><given-names>S</given-names></name><name><surname>De Weerdt</surname><given-names>A</given-names></name><name><surname>Malbrain</surname><given-names>M</given-names></name><name><surname>Vankersschaever</surname><given-names>D</given-names></name><name><surname>Frans</surname><given-names>E</given-names></name><name><surname>Wilmer</surname><given-names>A</given-names></name><etal/></person-group><article-title>Thrombocytopenia and prognosis in intensive care</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><fpage>1871</fpage><lpage>1876</lpage><pub-id pub-id-type="doi">10.1097/00003246-200006000-00031</pub-id><pub-id pub-id-type="pmid">10890635</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levi</surname><given-names>M</given-names></name><name><surname>Lowenberg</surname><given-names>EC</given-names></name></person-group><article-title>Thrombocytopenia in critically ill patients</article-title><source>Semin Thromb Hemost</source><year>2008</year><volume>34</volume><fpage>417</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1055/s-0028-1092871</pub-id><pub-id pub-id-type="pmid">18956281</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marck</surname><given-names>RE</given-names></name><name><surname>Montagne</surname><given-names>HL</given-names></name><name><surname>Tuinebreijer</surname><given-names>WE</given-names></name><name><surname>Breederveld</surname><given-names>RS</given-names></name></person-group><article-title>Time course of thrombocytes in burn patients and its predictive value for outcome</article-title><source>Burns</source><year>2013</year><volume>39</volume><fpage>714</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2013.01.015</pub-id><pub-id pub-id-type="pmid">23490002</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luzzani</surname><given-names>A</given-names></name><name><surname>Polati</surname><given-names>E</given-names></name><name><surname>Dorizzi</surname><given-names>R</given-names></name><name><surname>Rungatscher</surname><given-names>A</given-names></name><name><surname>Pavan</surname><given-names>R</given-names></name><name><surname>Merlini</surname><given-names>A</given-names></name></person-group><article-title>Comparison of procalcitonin and C-reactive protein as markers of sepsis</article-title><source>Crit Care Med</source><year>2003</year><volume>31</volume><fpage>1737</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000063440.19188.ED</pub-id><pub-id pub-id-type="pmid">12794413</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bargues</surname><given-names>L</given-names></name><name><surname>Chancerelle</surname><given-names>Y</given-names></name><name><surname>Catineau</surname><given-names>J</given-names></name><name><surname>Jault</surname><given-names>P</given-names></name><name><surname>Carsin</surname><given-names>H</given-names></name></person-group><article-title>Evaluation of serum procalcitonin concentration in the ICU following severe burn</article-title><source>Burns</source><year>2007</year><volume>33</volume><fpage>860</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2006.10.401</pub-id><pub-id pub-id-type="pmid">17532575</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsantes</surname><given-names>A</given-names></name><name><surname>Tsangaris</surname><given-names>I</given-names></name><name><surname>Kopterides</surname><given-names>P</given-names></name><name><surname>Kapsimali</surname><given-names>V</given-names></name><name><surname>Antonakos</surname><given-names>G</given-names></name><name><surname>Zerva</surname><given-names>A</given-names></name><etal/></person-group><article-title>The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study</article-title><source>Clin Chem Lab Med</source><year>2013</year><volume>51</volume><fpage>1535</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1515/cclm-2012-0562</pub-id><pub-id pub-id-type="pmid">23314554</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavrentieva</surname><given-names>A</given-names></name><name><surname>Papadopoulou</surname><given-names>S</given-names></name><name><surname>Kioumis</surname><given-names>J</given-names></name><name><surname>Kaimakamis</surname><given-names>E</given-names></name><name><surname>Bitzani</surname><given-names>M</given-names></name></person-group><article-title>PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment</article-title><source>Burns</source><year>2012</year><volume>38</volume><fpage>356</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2011.08.021</pub-id><pub-id pub-id-type="pmid">22037153</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Z</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name></person-group><article-title>Prognostic significance of serum procalcitonin in patients with burn sepsis</article-title><source>Zhonghua Shao Shang Za Zhi</source><year>2014</year><volume>30</volume><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">25174383</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Yang</surname><given-names>HT</given-names></name><name><surname>Hur</surname><given-names>J</given-names></name><name><surname>Chun</surname><given-names>W</given-names></name><name><surname>Ju</surname><given-names>YS</given-names></name><name><surname>Shin</surname><given-names>SH</given-names></name><etal/></person-group><article-title>Procalcitonin levels within 48 hours after burn injury as a prognostic factor</article-title><source>Ann Clin Lab Sci</source><year>2012</year><volume>42</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">22371911</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>B</given-names></name><name><surname>Koyfman</surname><given-names>A</given-names></name></person-group><article-title>Ready for prime time? Biomarkers in sepsis</article-title><source>Emerg Med Clin North Am</source><year>2017</year><volume>35</volume><fpage>109</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1016/j.emc.2016.09.004</pub-id><pub-id pub-id-type="pmid">27908327</pub-id></element-citation></ref></ref-list></back></article>